Uncategorized Archives - Page 74 of 145

ThursdaySep 23, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Continues to Increase Awareness of Novel Psychedelic Drug Candidates

Pharmaceutical company Tryp Therapeutics is preparing for clinical trials evaluating synthetic formulations of psilocybin to treat medical conditions with underpinning neurological causes The clinical trials planned are being conducted in partnership with research teams at the University of Florida and the University of Michigan Tryp executives have been meeting with investors at select conferences recently to increase awareness, including the just-completed Sept. 21 presentation at Oppenheimer’s Fall Healthcare Life Sciences & MedTech Summit The company expects to initiate Phase 2a trials to begin before the end of the year for treating certain eating disorders, with Phase 2b trials to follow…

WednesdaySep 22, 2021 10:30 am

Six Common Types of Brain Tumors

Cancer is an ailment that causes abnormal cells to grow and spread throughout the body. Brain cancer is an illness of the brain that causes masses made up of noncancerous or cancerous cells to form tumors in the brain. While there exists more than 100 types of brain cancer, most of the brain tumors can be categorized as either low-grade or high-grade tumors. Low-grade tumors grow slowly while high-grade tumors grow rapidly. Below is a list of the most common brain tumors. Glioblastoma An aggressive brain cancer type in adults, glioblastomas can be hard to remove and are known to…

WednesdaySep 22, 2021 9:00 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receives College of American Pathologists Accreditation for U.S. Laboratory

AnPac Bio’s clinical laboratories are located in the U.S. and China, with a total of 142 patents issued as of March 2021 Cancer Differentiation Analysis (“CDA”) technology is AnPac Bio’s approach to early cancer detection and screening technology, with over 200,000 samples and cases to serve as a way of approaching cancer screening Company’s ownership percentage in subsidiary AnPai (Shanghai) Healthcare Management Consultant Co. Ltd. has increased from 20% to 60%, following rigorous regulatory assessments and audits With a focus on early cancer screening and detection, biotechnology company AnPac Bio-Medical Science (NASDAQ: ANPC) recently announced that its U.S. laboratory has…

TuesdaySep 21, 2021 10:30 am

Nine Ways to Manage Stress

If you’ve been feeling stressed, identifying the cause of the stress and addressing it may help you feel better. University of Lancaster occupational health expert Gary Cooper says that turning to something unhealthy such as drinking or smoking will not help manage stress. However, adopting a positive outlook, remaining in control of your situation and building emotional strength might. Below are a few ways one can use to manage stress. Being positive Focus on the positive things in life and the things you are grateful for. You can do this by writing down three things that you’re grateful for or…

MondaySep 20, 2021 12:50 pm

RYAH Group Inc. (CSE: RYAH) Devices Ideal for Implementation of New Cannabis Intake Control Recommendations

Research team uses Delphi process for the first time to identify ideal cannabis dosing guidelines. After several rounds of voting, the ‘global task force’ created three separate dosing protocols. RYAH Group’s suite of precision dosing devices provide a practical way to safely execute these — or any — recommended dosing guidelines. Dosing recommendations are critical in any health treatments, but where cannabis is concerned, dosing levels have been tricky to identify. A recent blog from RYAH Group (CSE: RYAH) notes that a team of more than 20 cannabis experts have published consensus recommendations for dosing and administration of medical cannabis…

MondaySep 20, 2021 9:57 am

Patients with Unchanged Primary Care Physicians Have Superior Cancer Survival Rates

A study led by researchers from the Arnold School of Public Health at the University of South Carolina has discovered that in comparison to patients lacking continuity of care, individuals with continuity in their primary health care have lower mortality rates. The study was published in the “Health Services Research” journal. The lead author of the study, assistant professor Peiyin Hung of the University of South Carolina, stated that as the number of patients with cancer grows, a smooth transition in their care both before and after cancer diagnosis was necessary for the survival of patients in the long-term. Hung,…

FridaySep 17, 2021 1:54 pm

How to Address Various Health Inequities Using Digital Technologies

Digital technologies can be used to address various determinants of health by helping dismantle inequity. Below are a few factors of inequity that can be addressed by digital technologies. Unequal support for high medical expenses Every year, more than 900 million individuals spend roughly 10% of their household budget on healthcare expenses. Of this number, about 100 million are pushed into poverty because of this. While government financial schemes and health insurance are important protections for people, they aren’t widely available to marginalized communities. Digital financial services can help lay the groundwork for accessible insurance schemes which hinder catastrophic medical…

FridaySep 17, 2021 9:15 am

Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’

Nemaura’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor (“CGM”) designed for people with diabetes and prediabetes sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union, and Nemaura has submitted a premarket approval application to the U.S. FDA Nemaura continues to build a world-class management team Nemaura plans to launch a direct to consumer metabolic health program in 2021, using its glucose monitoring platform at the core of the program Nemaura has several patents (both filed and pending) and substantial trade secrets covering its technology platform…

FridaySep 17, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction will make InMed a global leader in the manufacturing of rare cannabinoids in addition to transforming it into a revenue-generating company Acquisition provides InMed with the complete flexibility across multiple manufacturing approaches On September 13, InMed Pharmaceuticals (NASDAQ: INM), a company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced it has signed a definitive agreement to acquire 100% of BayMedica…

FridaySep 17, 2021 9:00 am

Differentiated Approach in Psychedelics Boosts Confidence in Upcoming Clinical Trials for Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

Pharmaceutical company Tryp Therapeutics is pursuing novel solutions to medical conditions with unmet needs, working to establish the efficacy and safety of the company’s trademarked synthetic psychedelic drug candidate The company’s products — TRP-8802 and TRP-8803 — aim to provide new therapies for select eating disorders with specific neurological causes, as well as pain and addition concerns Tryp is preparing Phase 2a and Phase 2b clinical trials and expects to advance its Psilocybin-for-Neuropsychiatric Disorders (“PFN”) platform in conjunction with research teams at the University of Florida and the University of Michigan The DEA recently recommended a significant increase in cannabis…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Category: Uncategorized

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Continues to Increase Awareness of Novel Psychedelic Drug Candidates

Six Common Types of Brain Tumors

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receives College of American Pathologists Accreditation for U.S. Laboratory

Nine Ways to Manage Stress

RYAH Group Inc. (CSE: RYAH) Devices Ideal for Implementation of New Cannabis Intake Control Recommendations

Patients with Unchanged Primary Care Physicians Have Superior Cancer Survival Rates

How to Address Various Health Inequities Using Digital Technologies

Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

Differentiated Approach in Psychedelics Boosts Confidence in Upcoming Clinical Trials for Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search